GDC-0575

Names

[ CAS No. ]:
1196504-54-7

[ Name ]:
GDC-0575

Biological Activity

[Description]:

GDC0575 (ARRY-575) hydrochloride is a highly-selective and orally active Chk1 (IC50=1.2 nM) inhibitor. GDC0575 (ARRY-575) hydrochloride can be used for colitis-associated cancer (CAC) and colitis research[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Cell Cycle/DNA Damage >> Checkpoint Kinase (Chk)

Research Areas >> Inflammation/Immunology

[Target]

Chk1:1.2 nM (IC50)

[In Vitro]

GDC-0575 dihydrochloride 是一种选择性的具有口服活性的 CHK1 抑制剂，IC50为 1.2 nM。GDC-0575 (100 nM) 通过降低 tyr15 磷酸化 CDK2 水平抑制 AraC 诱导的 CHK1 激活[1]. GDC-0575 dihydrochloride (100 nM) 对 AML 细胞活力无影响，但与 AraC 联合使用可显著降低细胞活力，诱导细胞凋亡。GDC-0575 dihydrochloride 加 AraC 对正常造血干细胞 (HSPCs) 无影响[1]。GDC-0575 dihydrochloride 对 20 种黑色素瘤细胞系显示出细胞毒活性，但一些作为肿瘤球 (TS) 生长的细胞系相对不敏感[2]。

[In Vivo]

GDC-0575 dihydrochloride (7.5 mg/kg, p.o.) 联合 AraC 几乎可以完全消除移植 U937-Luc 细胞小鼠的白血病负担，并且比单独使用 AraC 更有效。GDC-0575 dihydrochloride 在体内不同原发性 AML 模型中提高 AraC 的细胞毒性[1]. GDC-0575 dihydrochloride (25、50 mg/kg, p.o.) 对 D20 和 C002 异种移植物肿瘤生长的剂量依赖性抑制作用[2].

[References]

[1]. Oo ZY, et al. Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo. Clin Cancer Res. 2018 Mar 13.

[2]. Laroche-Clary A, et al. CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications. Ann Oncol. 2018 Apr 1;29(4):1023-1029.

[3]. Di Tullio A, et al. The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia. Nat Commun. 2017 Nov 22;8(1):1679.

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₆H₂₁BrClN₅O

[ Molecular Weight ]:
414.73

[ Storage condition ]:
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.